Adenovirus Based Coronavirus Vaccine Being Tested
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]
WHO Reveals Underlying Concerns Over the Safety of Vaccines
During Dec. 2-3, 2019, the World Health Organization (WHO) held a Global Vaccine Safety Summit in Geneva, Switzerland. It was billed as an event for “vaccine safety stakeholders.” Attendees included current and former members of the Global Advisory Committee on Vaccine Safety (GACVS), which provides “independent, authoritative, scientific advice” to WHO on vaccine safety issues […]
Infant Boy in India Dies Day After Receiving Pentavalent Vaccine
A two-month-old infant boy died on Jan. 11, 2020, a day after receiving the “5-in-1” pentavalent (diphtheria, pertussis, tetanus, hepatitis B and Haemophilus influenzae type B) vaccine at a rural child care center in Hunshyal, India. The child was rushed to a nearby hospital after he fainted, but he died on the way.1 The child, […]
HIV Vaccine Fails Clinical Trial in South Africa
Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]
Cholera Vaccine Recommended by European Medicines Agency
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of the single-dose oral cholera vaccine Vaxchora, developed by multinational biopharmaceutical firm Emergent BioSolutions, Inc. of Gaithersburg, Maryland. On Jan. 30, 2020, the CHMP adopted a “positive opinion” on the granting of a marketing authorization for the bacterial […]